Moderna, BioNTech on the rise amid concerns over new variant, China outbreak

Mar. 14, 2022 11:10 AM ETModerna, Inc. (MRNA), NVAX, BNTX, PFEJNJ, AZNBy: Jonathan Block, SA News Editor104 Comments

Image of a world globe map with vials for the global SARS/COVID pandemic vaccine war, with vaccine hoarding, restricting equal access to vaccines across the world, counteracted by the Covax programme and global vaccine alliance

FrankyDeMeyer/iStock via Getty Images

  • Many vaccine makers are surging in Monday trading amid concerns over a new COVID-19 variant, deltacron, and as China experiences its worst outbreak since early 2020.
  • Moderna (MRNA +17.6%), BioNTech (BNTX +15.9%

Recommended For You

Comments (104)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.